Embed Size (px)
Citation preview
Introducing
The Ophthalmic Drug Development
AllianceTM
Encompass Pharmaceutical Services, Inc.
Rick Coulon
Director, Marketing & Business Development
150 Technology Parkway, NW
Norcross, GA 30092
770-248-4501 ext 260 o
770-330-1659 m
www.encompass-ophtha.comPharmOptima, LLC
James Vrbanac, PhD
VP, Business Development
6710 Quality Way
Portage, Michigan 49002
269-492-3872 o
269-352-9171 m
www.pharmoptima.com
Biological Test Center (BTC)
Stacy Pritt, DVM, MS, MBA, CPIA
Director & General Manager
2525 McGaw Avenue
Irvine, CA 92614-9791
949-660-3185 o
www.biologicaltestcenter.com
• Preclinical formulation support & evaluation
• Formulation, drug delivery, delivery optimization
• Clinical supplies & manufacturing support
• Analytical services
• Early drug discovery services including drug discovery assay and HTS
• Preclinical safety and efficacy, AAALAC and OLAW facilities, GLP in-life and bioanalytical, large and small species
• Preclinical models of glaucoma, macular degeneration, retinoblastoma, uveitis, and more
• State-of-the-art diagnostic capabilities including optical coherence tomography (OCT), electroretin- ography (ERG), intraocular pressure (IOP), visual evoked potentials (EVP), fluorescein angiography (FA), indocyanine green chorioangiography (ICG or ICG angiography), diagnostic autofluorescence, and more
• Full range of preclinical DM&PK; MS expertise
• Proof of concept to IND enabling studies
Successful IND filings require studies in two areas;
Preclinical Pharmacology and Toxicology, and
Chemistry Manufacturing and Control. We are
combining forces to offer you a full range of
ophthalmic discovery, pre-clinical efficacy, DM&PK
and GLP Safety, and formulation services from
pre-formulation through scale-up. Our innovative
development process combines state of the art
in-vitro/in-vivo screening studies to efficiently and
effectively speed ophthalmic drug evaluation &
development.
www.encompass-ophtha.com www.biologicaltestcenter.com www.pharmoptima.com
The Ophthalmic Drug Development AllianceTM
Encompass Pharmaceutical Services,
Biological Test Center (BTC) and
PharmOptima are pleased to announce
a strategic partnership dedicated to
meet the unique challenges of
ophthalmic drug discovery &
development leading to successful
regulatory filings.
